丹参酮IIA

40. [IF=3.8] Ying Zhang et al."Elucidating the distinctive regulatory effects and mechanisms of active compounds in Salvia miltiorrhiza Bunge via network pharmacology: Unveiling their roles in the modulation of platelet activation and thrombus formation."TOXICOLOGY AN 39. [IF=2] Fanhui Yang et al."Tanshinone IIA alleviates early brain injury after subarachnoid hemorrhage in rats by inhibiting the activation of NF-κB/NLRP3 inflammasome."BIOLOGICAL & PHARMACEUTICAL BULLETIN. 38. [IF=7.9] Dengxuan Mao et al."Tanshinone IIA normalized Hepatocellular Carcinoma vessels and enhanced PD-1 inhibitor efficacy by inhibiting ELTD1."PHYTOMEDICINE.2023 Nov;:155191 37. [IF=0] Yanshan Zhan et al."Preparation of tanshinone IIA self-soluble microneedles and its inhibition on proliferation of human skin fibroblasts."Chinese Herbal Medicines.2023 Jan;: 36. [IF=3.889] Chen Jia et al."Investigation of the mechanism of tanshinone IIA to improve cognitive function via synaptic plasticity in epileptic rats."PHARMACEUTICAL BIOLOGY. 35. [IF=5.988] 34. [IF=3.69] Ke-Yu Peng et al."Salvia miltiorrhiza stems and leaves total phenolic acids combination with tanshinone protect against DSS-induced ulcerative colitis through inhibiting TLR4/PI3K/AKT/mTOR signaling pathway in mice."J Ethnopharmacol. 2021 Jan;264:113052 33. [IF=6.291] Hao Yang et al."Recovery of chicken growth plate by TanshinoneⅡA through wnt/β-catenin pathway in thiram-induced Tibial Dyschondroplasia."Ecotox Environ Safe. 2019 Nov;183:109575 32. [IF=4.462] Zhe Li et al."Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA."Artificial Cells Nanomedicine and Biotechnology. 2018 Jan 29 31. Miao-Juan Shi, Xiu-Li Yan, Ben-Sheng Dong, Wen-Na Yang, Shi-Bing Su, Hui Zhang, A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis, Journal of Ethnopharmacology, Volume 253, 2020, 112689, IS 30. Li, Zhe, et al. "Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia." International Journal of Pharmaceutics 586 (2020): 119576.https://doi.org 29. Lübtow, Michael M., et al. "Like dissolves like? A comprehensive evaluation of partial solubility parameters to predict polymer–drug compatibility in ultrahigh drug-loaded polymer micelles." Biomacromolecules 20.8 (2019): 3041-3056.https://doi.org/10.1021 28. Yang, Runyu, et al. "Limonin ameliorates acetaminophen-induced hepatotoxicity by activating Nrf2 antioxidative pathway and inhibiting NF-κB inflammatory response via upregulating Sirt1." Phytomedicine 69 (2020): 153211.https://doi.org/10.1016/j.phymed.2020 27. Ding, B., Lin, C., Liu, Q. et al. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro. J Neuroinflammation 17, 302 (2020). https://doi.org/10.1186/s12974-020-01981-4 26. Li, Zhe, et al. "Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA." Artificial cells, nanomedicine, and biotechnology 46.sup1 (2018): 578-587.https://doi.org/1 25. 何珊,付先军,张玲,彭霄,王振国.响应面法优化丹参有效成分的提取工艺及其体外抗氧化活性研究[J].中华中医药学刊,2021,39(01):28-32+266-267. 24. 黑小斌,李欢,李慧,梁小燕,高静,彭亮,李依民,张岗.丹参无菌培养体系构建及有效成分含量的HPLC分析[J].中草药,2020,51(22):5833-5838. 23. 乔羽君,贾晨,曹爱佳,张睿,华玺,焦海胜.丙戊酸钠对丹参酮ⅡA在癫痫大鼠体内药动学的影响[J].现代中药研究与实践,2020,34(06):31-35. 22. 崔伟亮. 丹参酒炙前后HPLC指纹图谱色谱峰归属比较[J]. 辽宁中医杂志, v.46;No.507(08):1707-1709. 21. 王芸, 陈军峰, 张磊,等. 基于"有效成分-性状"的关联分析评价丹参品质的研究[J]. 世界科学技术:中医药现代化, 2019(5):835-843. 20. 敏敏 赵志国 刘伟 等. HPLC-DAD法同时测定三种来源丹参饮片中水溶性和脂溶性成分[J]. 山东科学 2019(6). 19. 牛敏 刘红燕 刘谦 等. 4个栽培年限丹参颜色与9种活性成分含量的相关性[J]. 中成药 2017(1):131-135. 18. 尉广飞 李佳 刘谦 等. 丹参根部颜色及其与活性成分含量的相关性研究[J]. 山东农业科学 2015(08):59-62. 17. 尉广飞 刘谦 李佳 等. 丹参根部活性成分分布规律研究[J]. 山东科学 2015 28(05):7-13. 16. 梁从莲 张永清 李佳 等. 不同株系丹参有效成分比较研究[J]. 山东科学 2018(4):31-38. 15. 支旭然 刘洪涛 吴茵 等. UPLC-MS/MS法同时测定肾康注射液中7个有效成分[J]. 药物分析杂志 2017 037(001):37-42. 14. 李翠, 尉广飞, 李佳,等. 性状异常丹参的利用价值研究[J]. 山东科学, 2014, 27(002):39-43. 13. 尉广飞 李翠 刘谦 等. 丹参根部直径与其活性成分含有量间的相关性研究[J]. 中成药 2015 37(008):1780-1784. 12. 闫妍 石磊 史宁 郭宏举 耿帅 温彬宇.UPLC-Q-TOF-MS同时测定天王补心片中丹参的主要成分[J].解放军药学学报 2018 34(01):55-57. 11. 曹张琦,徐静汶,路莉,胡燕,罗臻,李鸿源,王学习.扶正通络颗粒质量标准研究[J].中国新药杂志,2019,28(11):1372-1377. 10. 张玉, 戚莹雪, 王蕾,等. 山东丹参脂溶性成分的地域分布特点研究[J]. 中药材, 2018, 041(011):2522-2526. 9. 张芮乾,吴晓毅,胡添源,宋雅迪,高伟,黄璐琦.基于丹参酮类化合物生源途径的丹参质量标志物研究思路探讨[J].中国中药杂志,2020,45(13):3098-3103. 8. 马东来 刘爱朋 林悦 谢赟 刘涛 朱峰莉 楚立.丹参有效成分与铁离子的相互作用[J].广州化工 2017 45(14):117-118+144. 7. 温静, 唐雪阳, 李焕娟,等. 基于药物体系质量评价模式的丹参质量表征关联分析研究[J]. 中华中医药学刊, 2015, 033(004):843-846. 6. 刘蕾,杨玉洁,王凌,蒋学华.在“三明治”培养大鼠原代肝细胞中研究利福平及联用丹参酮ⅡA对普伐他汀经BSEP转运的影响[J].中国药理学通报,2019,35(07):978-985. 5. 李敏 周静 虞立 等. 丹参酮ⅡA提取工艺的优化[J]. 中成药 2018 040(003):741-744. 4. 赵丽萍 张琳成 陈冰 等. 丹参酮ⅡA对脑缺血再灌注损伤大鼠神经保护作用的研究[J]. 中华中医药学刊 2019(9). 3. 王红艳 蔡凡 徐春亮 等. 丹参酮ⅡA对内皮细胞环氧合酶2表达的影响及相关机制[J]. 中国动脉硬化杂志 2014 22(010):997-1000. 2. 苏志彩 邵蔚 张芳玲.丹参酮ⅡA对N-甲基-D-天冬氨酸诱导的视网膜神经节细胞损伤的保护作用[J].实用老年医学 2018 32(11):1009-1012. 1. 吴瑶 宋囡 贾连群 等. 丹参酮ⅡA对ApoE?/?小鼠肝脏脂质沉积及铁死亡相关蛋白表达的影响[J]. 中国病理生理杂志 2020年36卷7期 1261-1268页 ISTIC PKU CSCD CA 2020.